## Hi there ğŸ‘‹

# ğŸ‘‹ Hi, I'm Raju Kumar

AI/ML Program Leader | Generative AI | Pharma Digital Transformation | PMP  

I design and lead AI-driven innovation programs across regulated pharmaceutical environments, bridging business strategy, data science, and technology execution.

---

## ğŸ§  What I Focus On

- AI/ML Innovation Lab Programs
- Generative AI & Agentic AI Solutions
- LLMs & Retrieval-Augmented Generation (RAG)
- AI Governance & Compliance in Regulated Industries
- PoC â†’ Pilot â†’ MVP Lifecycle Execution
- Cross-functional Agile Program Leadership

---

## ğŸ”¬ Featured AI Projects

- ğŸ©º Lightweight Medical Q&A Assistant fine-tuned on MiniLM using curated MedQuAD dataset via AutoTrain  
- ğŸ¤– AI-Powered Customer Query Response Chatbot using RAG architecture  
- ğŸ“Š AI-Driven Customer Product Review Sentiment Analyzer using LLMs  
- ğŸ¥— Diabetic Diet & Habit Planner built as a No-Code Generative AI App using AWS PartyRock  
- ğŸ’° Strategic ROI Model Developed for Clinical Trial Adverse Event Classifier AI Solution  

---

## ğŸ— My Approach to AI Delivery

I believe AI success requires more than models. It requires:

- Clear business alignment  
- Strong governance frameworks  
- Measurable KPIs  
- Risk-aware architecture  
- Scalable deployment strategy  

My focus is on delivering AI solutions that move from experimentation to enterprise-grade impact.

---

## âš™ï¸ Tech & Tools

Python | OpenAI | HuggingFace | LLMs | RAG | NLP  
Azure AI | Cloud-Ready Architectures  
MSP | Jira | Tableau | SAP  
Agile | Program Governance | KPI Dashboards  

---

## ğŸ“Š Background

- 14+ years in enterprise transformation and program management 
- AI & Digital programs  
- Strategy deployment across Europe
- Regulatory-compliant digital platforms (GxP, GDPR)
- Project and Program Management in Pharmaceutical and Biopharmaceutical industry

---

## ğŸ“« Connect With Me

LinkedIn: linkedin.com/in/programdirectorai  
email: rajucanon@yahoo.com
Location: Hyderabad, India  

---

â­ Exploring how AI can responsibly transform life sciences.
